Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pantano

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Oncotarget|March 25, 2020
Prognostic and predictive factors in pancreatic cancerEmanuela Dell'Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, et al.
Anticancer Research|May 6, 2021
Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and SurvivalPaolo Orsaria, Antonella Grasso, Edy Ippolito, et al.
Oncotarget|April 24, 2015
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironmentMichele Iuliani, Francesco Pantano, Consuelo Buttigliero, et al.
Frontiers in Oncology|April 3, 2023
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patientsEdy Ippolito, Sonia Silipigni, Francesco Pantano, et al.
Journal of Clinical Medicine|July 12, 2025
Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6Edy Ippolito, Lucrezia Toppi, Sofia Carrafiello, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and BiomarkersMarco Russano, Giulia La Cava, Alessio Cortellini, et al.
Frontiers in Oncology|April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysisRoberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
The Oncologist|July 24, 2025
Trastuzumab-Deruxtecan and Radiotherapy: A Safety Sub-Analysis of Combart Prospective Cohort StudyEdy Ippolito, Martina Benincasa, Francesco Pantano, et al.
Scientific Reports|March 18, 2025
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcomaFrancesca Zalfa, Paolo Manca, Simone Carotti, et al.
Human Immunology|April 29, 2009
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian populationSilvia Angeletti, Sara Galluzzo, Daniele Santini, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Oncotarget|March 25, 2020
Prognostic and predictive factors in pancreatic cancerEmanuela Dell'Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, et al.
Anticancer Research|May 6, 2021
Clinical Outcomes Among Major Breast Cancer Subtypes After Neoadjuvant Chemotherapy: Impact on Breast Cancer Recurrence and SurvivalPaolo Orsaria, Antonella Grasso, Edy Ippolito, et al.
Oncotarget|April 24, 2015
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironmentMichele Iuliani, Francesco Pantano, Consuelo Buttigliero, et al.
Frontiers in Oncology|April 3, 2023
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patientsEdy Ippolito, Sonia Silipigni, Francesco Pantano, et al.
Journal of Clinical Medicine|July 12, 2025
Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6Edy Ippolito, Lucrezia Toppi, Sofia Carrafiello, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and BiomarkersMarco Russano, Giulia La Cava, Alessio Cortellini, et al.
Frontiers in Oncology|April 10, 2024
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysisRoberta Caputo, Giuseppe Buono, Michela Piezzo, et al.
The Oncologist|July 24, 2025
Trastuzumab-Deruxtecan and Radiotherapy: A Safety Sub-Analysis of Combart Prospective Cohort StudyEdy Ippolito, Martina Benincasa, Francesco Pantano, et al.
Scientific Reports|March 18, 2025
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcomaFrancesca Zalfa, Paolo Manca, Simone Carotti, et al.
Human Immunology|April 29, 2009
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian populationSilvia Angeletti, Sara Galluzzo, Daniele Santini, et al.
Pageof 13